BrackenMB, HolfordTR. Neurological and functional status 1 year after acute spinal cord injury: estimates of functional recovery in National Acute Spinal Cord Injury Study II from results modeled in National Acute Spinal Cord Injury Study III. J Neurosurg, 2002; 96:259–266.
FramptonAE, EynonCA. High dose methylprednisolone in the immediate management of acute, blunt spinal cord injury: what is the current practice in emergency departments, spinal units, and neurosurgical units in the UK?Emerg Med J, 2006; 23:550–553.
4.
GreenBA, KhanT, RaimondiAJ. Local hypothermia as treatment of experimentally induced spinal cord contusion: quantitative analysis of beneficient effect. Surg Forum, 1973; 24:436–438.
5.
GuptaR, BathenME, SmithJS, LeviAD, BhatiaNN, StewardO. Advances in the management of spinal cord injury. J Am Acad Orthop Surg, 2010; 18:210–222.
6.
HallED, SpringerJE. Neuroprotection and acute spinal cord injury: A reappraisal. NeuroRx, 2004; 1:80–100.
7.
HurlbertRJ. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg, 2000; 93:1–7.
8.
HurlbertRJ, HamiltonMG. Methylprednisolone for acute spinal cord injury: 5-year practice reversal. Can J Neurol Sci, 2008; 35:41–45.
9.
HurlbertRJ, MoultonR. Why do you prescribe methylprednisolone for acute spinal cord injury? A Canadian perspective and a position statement. Can J Neurol Sci, 2002; 29:236–239.
PandyaKA, WeantKA, CookAM. High-dose methylprednisolone in acute spinal cord injuries: proceed with caution. Orthopedics, 2010; 33:327–331.
15.
QianT, GuoX, LeviAD, VanniS, ShebertRT, SipskiML. High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients. Spinal Cord, 2005; 43:199–203.
16.
SayerFT, KronvallE, NilssonOG. Methylprednisolone treatment in acute spinal cord injury: The myth challenged through a structured analysis of published literature. Spine J, 2006; 6:335–343.
